UTI-lizer logo — Revolutionizes the Urinary Tract Infection diagnostics!

UTI-lizer

Revolutionizes the Urinary Tract Infection diagnostics!

Founded 2021 Sweden Sweden 10 employees Seed Total: $7.00M Biotechnology, Medical Devices

General Information

Company Name UTI-lizer
Founded Year 2021
Location Sweden Sweden +1
Employees 10
Industries Biotechnology, Medical Devices
Funding Stage Seed
Social

Get notified when UTI-lizer moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About UTI-lizer

UTI-lizer is a biotechnology startup revolutionizing urinary tract infection diagnostics. With the slogan "Revolutionizes the Urinary Tract Infection diagnostics!" the company addresses the issue of UTIs being the most common bacterial infections in women, with current over-the-counter tests not being sensitive enough. Founded in 2021 and headquartered in Sweden, the company secured a kr7.00MSeed Round investment on 17 May 2023 with investors including Almi Invest and Sting. The company's novel approach involves miniaturizing culture-based bacterial detection in a dipstick format with a highly sensitive and quantitative digital bioassay, enabling the detection and quantification of bacteria in the clinically relevant range. This can be achieved without the need for complicated lab instruments, with a readout accessible by the naked eye or a simple cell phone camera. UTI-lizer's diagnostic test stands out due to its ability to empower non-trained operators to detect urinary tract infections in the clinically relevant range in a home setting, promising a significant impact on UTI diagnostics and treatment.

Taxonomy: Urinary Tract Infections, UTI diagnostics, Bacterial detection, Diagnostic test, Home testing, Point-of-care technology, Healthcare innovation, Medical technology, Bioassay, Digital healthcare, Women's health, Antibiotic stewardship

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round - UTI •••••• 2
Investor
•••• ••••
17 May 2023
Non Equity Assistance - UTI •••••• 1
Investor
09 Sep 2022

UTI-lizer Alternatives & Competitors

UTI-lizer vs

Fast & Simple Syndromic PCR Testing for Severe Infections - Improving Patient Outcomes

Post Ipo Debt
28 employees
Biotechnology
UTI-lizer vs

At Minnesota Women’s Care, we believe in providing the best preventive care based on each woman's un...

55 employees
Health Care
UTI-lizer vs

Your Center for Comprehensive Urological Care

98 employees
Health Care

FAQ About UTI-lizer

Revolutionizes the Urinary Tract Infection diagnostics!
UTI-lizer was founded in 2021.
UTI-lizer is headquartered in Sweden.
UTI-lizer operates in the following industries: Biotechnology, Medical Devices.
UTI-lizer has approximately 10 employees.
UTI-lizer has completed 2 funding rounds, raising a total of $7.00M. The latest funding stage is Seed.
Top alternatives and competitors to UTI-lizer include Curetis GmbH, Minnesota Women's Care, The Urology Center of Colorado, DEBN Sp. z o.o., BioDerm Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
UTI-lizer and Curetis GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors UTI-lizer and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy